Protara Therapeutics Statistics

Total Valuation

TARA has a market cap or net worth of $41.80 million. The enterprise value is -$8.20 million.

Market Cap	41.80M
Enterprise Value	-8.20M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

TARA has 20.59 million shares outstanding. The number of shares has increased by 1.04% in one year.

Shares Outstanding	20.59M
Shares Change (YoY)	+1.04%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	6.18%
Owned by Institutions (%)	42.15%
Float	13.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.72
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.53, with a Debt / Equity ratio of 0.09.

Current Ratio	10.53
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.80% and return on invested capital (ROIC) is -71.87%.

Return on Equity (ROE)	-58.80%
Return on Assets (ROA)	-51.40%
Return on Capital (ROIC)	-71.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.63M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.48% in the last 52 weeks. The beta is 1.90, so TARA's price volatility has been higher than the market average.

Beta (5Y)	1.90
52-Week Price Change	-17.48%
50-Day Moving Average	2.77
200-Day Moving Average	2.49
Relative Strength Index (RSI)	31.91
Average Volume (20 Days)	191,136

Short Selling Information

The latest short interest is 1.72 million, so 8.38% of the outstanding shares have been sold short.

Short Interest	1.72M
Short Previous Month	1.58M
Short % of Shares Out	8.38%
Short % of Float	12.59%
Short Ratio (days to cover)	5.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-45.73M
Pretax Income	-42.47M
Net Income	-42.47M
EBITDA	-42.12M
EBIT	-42.47M
Earnings Per Share (EPS)	-$3.74

Full Income Statement

Balance Sheet

The company has $55.22 million in cash and $5.23 million in debt, giving a net cash position of $50.00 million or $2.43 per share.

Cash & Cash Equivalents	55.22M
Total Debt	5.23M
Net Cash	50.00M
Net Cash Per Share	$2.43
Equity (Book Value)	58.41M
Book Value Per Share	2.84
Working Capital	52.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.05 million and capital expenditures -$39,000, giving a free cash flow of -$35.09 million.

Operating Cash Flow	-35.05M
Capital Expenditures	-39,000
Free Cash Flow	-35.09M
FCF Per Share	-$3.07

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TARA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.04%
Shareholder Yield	-1.04%
Earnings Yield	-101.61%
FCF Yield	-83.94%

Analyst Forecast

The average price target for TARA is $25.00, which is 1,131.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	1,131.53%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 10, 2020. It was a reverse split with a ratio of 1:40.

Last Split Date	Jan 10, 2020
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	2